Health Trials

Dual-chamber Patient-controlled Analgesia for Postoperative Recovery

ConditionsMorbid ObesityPCAAnalgesiaPONV
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age19-65
SponsorSeoul National University Bundang Hospital

About this trial

Postoperative nausea and vomiting (PONV) are the most common complications that can occur after general anesthesia. Postoperative use of opioids and morbid obesity have been reported as risk factors of PONV. In this study, the investigators aimed to compare the degree of postoperative side effects and pain control when an intravenous patient-controlled analgesia combining fentanyl and ketorolac via a dual-chamber device was provided to participants undergoing laparoscopic sleeve gastrectomy.

Eligibility criteria

Qualifiers

Adult females aged 19 to 65 years

American Society of Anesthesiologists physical status (ASA class) 1 to 3

Patients scheduled for laparoscopic sleeve gastrectomy under general anesthesia

Patients requesting the use of IV-PCA after surgery

Disqualifiers

Patients with hypersensitivity to the drugs used in this study (Ketorolac, Fentanyl)

Patients with alcohol or drug dependence, long-term use of opioids or analgesics

Patients with liver disease or renal failure

Patients with peptic ulcer, patients with gastrointestinal bleeding predisposition

Trial design

Treatments tested in this trial

  • multimodal analgesia via dual-chamber PCA
  • single regimen (only fentanyl)

Treatment groups

92 Participants
are divided into 2 treatment groups

Locations

1
Seoul National University Bundang Hospital13620, Seongnam-siGyunggi-do, South Korea

Sponsors and collaborators

Seoul National University Bundang Hospital

Lead sponsor

Source ClinicalTrials.gov